(Press-News.org) At EPFL's School of Engineering, Professor Li Tang's Laboratory of Biomaterials for Immunoengineering has made significant strides in cancer treatment research. In laboratory settings, this innovative CAR-T therapy has consistently eradicated cancerous tumors in mouse models. Separately, in on-going clinical trials, eleven patients seemed to achieve complete remission using this treatment, marking a success rate of 100% to date. Notably, evidence from the lab study, published in Nature Biotechnology, suggests the therapy's long-term effectiveness, and indicates that its fabrication may be both quicker and more cost-effective than current methods.
At its core, CAR-T therapy involves modifying T-cells to target and eliminate specific cancer cells. These modified T-cells are equipped with Chimeric Antigen Receptors (CARs) that allow them to recognize and latch onto cancer cells, marking a significant departure from traditional treatments. “We’ve added another layer to the CAR-T cell therapy by bioengineering a more robust, supercharged immune cell that is particularly efficient at targeting and destroying tumor cells,” says Tang. The start-up Leman Biotech, co-founded by Tang and paper co-author Yugang Guo, aims to commercialize the treatment. The company has already garnered significant financial backing in its initial fundraising rounds.
Professor Li Tang's groundbreaking research adds another dimension to this innovative approach. Traditional CAR-T cells, while effective against liquid cancers, face challenges in solid tumors—the cells wear themselves out and ultimately failing to fully destroy the cancer. Professor Tang's research introduces CAR-T cells that excrete the IL-10 molecule, which is then ingested by the modified T cells. In other words, the cell has been engineered to produce its own medicine to keep healthy in the tumor’s hostile environment.
Surprisingly, the IL-10 molecule was traditionally viewed as an immune suppressant. But instead of inhibiting the immune response, Tang and his team have leveraged its unique metabolic reinforcement capabilities. This innovative twist bolsters the metabolism of the CAR-T cells. These metabolically armored treatments work immediately on existing tumors and have been shown to prevent future tumors from coming back.
Even after the reintroduction of tumor cells into the mouse models, the cells failed to establish themselves or show any malignancy. This underscores the lasting efficacy of the treatment, where the immune response remains vigilant and effectively neutralizes any renewed cancer threats. “The results in my lab are extremely exciting. We are convinced that this technology has the potential to save lives—as it has done so far with the 12 patients involved in our trial,” says Tang.
While current CAR-T cell therapy has proven effective and several treatments options are currently available for leukemia and other liquid cancers, it remains extremely expensive: The cost of one treatment is upwards of $500k. In contrast, the costs of this future treatment could be significantly lowered due to the fact that only five percent of the traditional dose is necessary for full recovery. Much of the costs come from the fabrication of relatively large amounts of these modified T-cells in expensive laboratory environments. “A small amount of blood from a patient could provide already enough cells to prepare CAR-T cell therapy with our technology. The next day you can already inject them back to the patient. It will be substantially less expensive and much faster to produce, saving more lives in the end” concludes Tang. Tang’s team and Leman Biotech is currently working toward that goal.
Reference: Zhao, Y., Chen, J., Andreatta, M., Feng, B., Xie, Y-Q., Wenes, M., Wang, Y., Gao, M., Hu, X., Romero, P., Carmona, S., Sun, J., Guo, Y-G., & Tang, L. (2023). Metabolically armored CAR-T cells counter dysfunction and promote stemness for solid tumor clearance. Nature Biotechnology. https://doi.org/10.1038/s41587-023-02060-8
END
Supercharging CAR-T cells for cancer treatment
Transformative research at EPFL introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy
2024-01-04
ELSE PRESS RELEASES FROM THIS DATE:
Minimizing immunotherapy’s potentially harmful side effects
2024-01-04
MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 4, 2024, at 10 AM EST) – Recent advances in treating multiple myeloma, the second most common blood cancer, and other blood malignancies are providing improved outcomes – and hope – to patients worldwide.
But treatment breakthroughs such as the immunotherapy drug teclistamab can lead to potentially lethal side effects, including cytokine release syndrome (CRS) and immune cell-associated neurotoxicity syndrome (ICANS).
These potential side effects have necessitated giving immunotherapy drugs in the hospital setting, where patients remain for five to seven days and receive other drugs ...
Study finds paxlovid treatment does not reduce risk of long COVID
2024-01-04
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found a higher proportion of individuals with acute symptoms rebound and test-positivity than previously reported.
The study appears Jan. 4, 2024, in the Journal of Medical Virology.
Paxlovid treatment for acute COVID-19 has been shown to be effective for high-risk unvaccinated individuals. But the effect of the treatment on long COVID risk, including whether it protects vaccinated people from getting long COVID, has been less clear.
The ...
Menarini Group and Insilico Medicine enter global exclusive license agreement for novel KAT6 inhibitor for potential breast cancer treatment and other oncology indications
2024-01-04
● KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor clinical outcomes in patients with ER+/HER2- breast cancer – the most common subtype.
● The molecule has demonstrated strong preclinical activity. Insilico Medicine presented data on the novel molecule at the San Antonio Breast Cancer Symposium in early December.
● This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
FLORENCE, Italy and NEW YORK: The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...
New population risk prediction model for likelihood of ICU admission and survival
2024-01-04
INDIANAPOLIS – A significant obstacle to improving care and outcomes for intensive care unit (ICU) patients is the unexpected nature of becoming seriously ill. Which groups of patients are likely to become severely ill and will they survive their ICU stay?
In a first step in creating infrastructure for further studies to identify and follow cohorts of patients who may become critically ill, researchers including Sikandar Khan, D.O, M.S., of Regenstrief Institute and Indiana University School of Medicine, have developed and conducted ...
Chung-Ang University study reveals a higher market valuation of cash holdings of firms adopting electronic voting
2024-01-04
Firms worldwide are increasingly adopting electronic voting, enabling shareholders to cast their votes online, instead of attending shareholder meetings in-person. Shareholders can enjoy superior accessibility to the meetings with electronic voting, compared to those with traditional and in-person setups. Despite the emerging popularity of electronic voting in recent years, however, there is limited evidence of its impact on governance.
To address this gap in research, Associate Professor Wonsuk Ha from the School of Business Administration, Chung-Ang University, along ...
Women undergoing fertility treatment who are stressed may have heart health issues during pregnancy
2024-01-04
WASHINGTON—A new Journal of the Endocrine Society study among women attending a fertility center found that those with more stress before pregnancy had higher blood sugar levels during pregnancy, which is a sign of weaker cardiovascular health.
People’s stress levels have continued to rise over the years, particularly in the last few years due to the COVID-19 pandemic, putting them at risk for serious health issues such as heart disease. Research shows women may experience more stress than men, especially those going through infertility. Maintaining a healthy pregnancy ...
Study finds preconception stress may affect health of women undergoing fertility treatment
2024-01-04
Stress during pregnancy is known to influence health outcomes, but a new study from Mass General Brigham researchers suggests that stress levels before pregnancy are also important to evaluate. Investigators at Massachusetts General Hospital and Brigham and Women’s Hospital analyzed the link between self-reported stress immediately before conception among women seeking fertility care and blood glucose levels, a marker of heart health. The team found that maternal stress during preconception ...
AI-driven study redefines right heart health assessment with novel predictive model
2024-01-04
New York, NY [January 4, 2023]—In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart’s right ventricle, which sends blood to the lungs.
Conducted by a team using AI-enabled electrocardiogram (AI-ECG) analysis, the research demonstrates that electrocardiograms can effectively predict right-side heart issues, offering a simpler alternative to complex imaging technologies and potentially enhancing patient outcomes.
The findings were described in the December 29 online ...
Better mental, physical health in older people tied to living near nature
2024-01-04
SPOKANE, Wash. – Even small differences in the availability of urban green and blue spaces may be associated with better mental and physical health in older adults, according to a Washington State University study.
The study’s findings showed that having just 10% more forest space in a person’s residential ZIP code was associated with reduced serious psychological distress, which covers mental health problems that require treatment and interfere with people’s social lives, work or school. Similarly, a 10% increase in green space, tree cover, water bodies ...
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health
2024-01-04
100 years of Science Changing Life: Scripps Research celebrates a century of transforming human health
LA JOLLA, CA—Scripps Research, a nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation, will celebrate its 100-year history throughout 2024. This significant milestone marks a century of seminal discoveries in immunology, infectious diseases (such as COVID-19, flu, HIV), neuroscience, heart disease, cancer, and more. The institute has also made strides in groundbreaking chemistry advances, drug development and educational ...
LAST 30 PRESS RELEASES:
What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids
ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000
Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work
Turning social fragmentation into action through discovering relatedness
Cheese may really be giving you nightmares, scientists find
Study reveals most common medical emergencies in schools
Breathable yet protective: Next-gen medical textiles with micro/nano networks
Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems
Developed an AI-based classification system for facial pigmented lesions
Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing
New book Terraglossia reclaims language, Country and culture
The most effective diabetes drugs don't reach enough patients yet
Breast cancer risk in younger women may be influenced by hormone therapy
Strategies for staying smoke-free after rehab
Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy
Study projects over 14 million preventable deaths by 2030 if USAID defunding continues
New study reveals 33% gap in transplant access for UK’s poorest children
Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)
IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer
It takes a village: Chimpanzee babies do better when their moms have social connections
From lab to market: how renewable polymers could transform medicine
Striking increase in obesity observed among youth between 2011 and 2023
No evidence that medications trigger microscopic colitis in older adults
NYUAD researchers find link between brain growth and mental health disorders
Aging-related inflammation is not universal across human populations, new study finds
University of Oregon to create national children’s mental health center with $11 million federal grant
Rare achievement: UTA undergrad publishes research
Fact or fiction? The ADHD info dilemma
Genetic ancestry linked to risk of severe dengue
Genomes reveal the Norwegian lemming as one of the youngest mammal species
[Press-News.org] Supercharging CAR-T cells for cancer treatmentTransformative research at EPFL introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy